Skip to main content

Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.

Publication ,  Journal Article
Paldino, MJ; Wong, TZ; Reardon, DA; Friedman, HS; Barboriak, DP
Published in: Br J Radiol
April 2011

OBJECTIVE: The aim of this study was to determine the prognostic significance of the volume and intensity of abnormal (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) accumulation within areas of contrast enhancement on post-therapeutic volumetric MRI. METHODS: A total of 10 patients with Grade III or IV glioma were treated with resection followed by intracavitary radiation therapy with (131)I-labelled antitenascin monoclonal antibody. Patients underwent serial FDG-PET and 1.5 T MR imaging. For each patient, MR and FDG-PET image volumes at each time point were aligned using a rigid-body normalised mutual information algorithm. Contrast-enhancing regions of interest (ROIs) were defined using a semi-automated k-means clustering technique. Activity within the ROI on the co-registered PET scan was calculated as a ratio (mean activity ratio; MAR) to activity in contralateral normal-appearing white matter (NAWM). The PET lesion was defined as the portion of the ROI associated with activity greater than two standard deviations above the mean in NAWM. Survival was assessed using the logrank test. RESULTS: Larger contrast-enhancing ROIs were strongly associated with an increased MAR (r = 0.51; p<0.002). Enhancing lesions with an MAR >1.2 were associated with decreased survival (p<0.016). In nine patients who died, the MAR on PET correlated inversely with survival duration (r = -0.43; p<0.01), whereas PET lesion volume did not. CONCLUSION: Following intracavitary radiation therapy, the development of contrast-enhancing lesions that are associated with high mean FDG-PET accumulation suggests poor prognosis.

Duke Scholars

Published In

Br J Radiol

DOI

EISSN

1748-880X

Publication Date

April 2011

Volume

84

Issue

1000

Start / End Page

327 / 333

Location

England

Related Subject Headings

  • Radiopharmaceuticals
  • Prognosis
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Humans
  • Glioma
  • Fluorodeoxyglucose F18
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Paldino, M. J., Wong, T. Z., Reardon, D. A., Friedman, H. S., & Barboriak, D. P. (2011). Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma. Br J Radiol, 84(1000), 327–333. https://doi.org/10.1259/bjr/48528504
Paldino, M. J., T. Z. Wong, D. A. Reardon, H. S. Friedman, and D. P. Barboriak. “Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.Br J Radiol 84, no. 1000 (April 2011): 327–33. https://doi.org/10.1259/bjr/48528504.
Paldino, M. J., et al. “Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.Br J Radiol, vol. 84, no. 1000, Apr. 2011, pp. 327–33. Pubmed, doi:10.1259/bjr/48528504.
Paldino MJ, Wong TZ, Reardon DA, Friedman HS, Barboriak DP. Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma. Br J Radiol. 2011 Apr;84(1000):327–333.

Published In

Br J Radiol

DOI

EISSN

1748-880X

Publication Date

April 2011

Volume

84

Issue

1000

Start / End Page

327 / 333

Location

England

Related Subject Headings

  • Radiopharmaceuticals
  • Prognosis
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Humans
  • Glioma
  • Fluorodeoxyglucose F18